Filter Needles Market Size, Share & Trends Report 2023-2030: Global Analysis by Raw Material (Stainless Steel, Glass), and End-use (Hospital, Clinics, Ambulatory Surgery Centers) – ResearchAndMarkets.com

The “Filter Needles Market Size, Share & Trends Analysis Report By Raw Material (Stainless Steel, Glass, Others), By End-use (Hospital, Clinics, Ambulatory Surgery Centers, Others), By Region, And Segment Forecasts, 2023 – 2030″ report has been added to ResearchAndMarkets.com’s offering.

The global filter needles market size is expected to reach USD 2.9 billion by 2030. The market is expected to expand at a CAGR of 7.5% from 2023 to 2030.

The increasing geriatric population, technological advancements, and rising prevalence of chronic wounds are the key factors driving the market. The increasing prevalence of various chronic wounds across the globe is anticipated to drive the market over the forecast period. Some of the prevailing chronic wounds are diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Diabetic foot ulcers generally occur due to prolonged diabetes or low blood glucose level in patients. The increasing rate of diabetes in all age groups across the globe is a major factor responsible for the high prevalence of diabetic foot ulcers. As per studies conducted by the National Center for Biotechnology Information (NCBI), in 2017, the prevalence rate of diabetic foot ulcers in North America was 13.0% (highest), 5.5% in Asia, 7.2% in Africa, 5.1% in Europe, 1.5% in Australia, 16.6% in Belgium, 14.8% in Canada, and 13.0% in the U.S.

The incidence rate of pressure ulcers is rising owing to a rapidly aging population and an increase in the incidence of disabilities across the globe. In the U.S., around USD 11.0 billion is spent per year on pressure ulcers, as per the NCBI. Furthermore, the prevalence rate of pressure ulcers in nursing home patients is around 11.0% every year, therefore incidence and prevalence are anticipated to be high over the forecast period.

A venous leg ulcer is an open lesion between the ankle joint and knees mainly caused due to venous disease. It is the most common leg ulcer and the prevalence rate of venous leg ulcers ranges from 0.18% to 1.0%, as per NCBI. Venous leg ulcers are the most advanced form of chronic venous disorders and the recurrence rate of these ulcers is more than 70.0%. Such a high prevalence of chronic wounds is expected to boost market growth over the forecast period.

Filter Needles Market Report Highlights

  • In terms of revenue, the stainless steel segment held the largest market share in 2022 due to the presence of several players offering this product and low price
  • The hospitals segment held the largest revenue share in 2022 owing to the increasing number of hospitals across the globe
  • In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period owing to the rising road accident cases in this region

Company Profiles

  • BD
  • Cardinal Health
  • Myco Medical
  • Stryker
  • B.Braun SE
  • Sol-Millennium
  • Terumo Corporation
  • ICU Medical Inc.

Key Attributes:

Report Attribute Details
No. of Pages 110
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $1.6 Billion
Forecasted Market Value (USD) by 2030 $2.9 Billion
Compound Annual Growth Rate 7.5%
Regions Covered Global

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Raw material outlook

2.2.2. End use outlook

2.2.3. Regional outlook

2.3. Competitive Insights

Chapter 3. Filter Needles Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Penetration & Growth Prospect Mapping

3.3. Market Dynamics

3.3.1. Market driver analysis

3.3.2. Market restraint analysis

3.4. Filter Needles Market Analysis Tools

3.4.1. Industry Analysis – Porter’s

3.4.1.1. Supplier power

3.4.1.2. Buyer power

3.4.1.3. Substitution threat

3.4.1.4. Threat of new entrant

3.4.1.5. Competitive rivalry

3.4.2. PESTEL Analysis

3.4.2.1. Political landscape

3.4.2.2. Technological landscape

3.4.2.3. Economic landscape

Chapter 4. Filter Needles: Raw Material Estimates & Trend Analysis

4.1. Filter Needles Market, Key Takeaways

4.2. Filter Needles Market: Movement & Market Share Analysis, 2022 & 2030

4.3. Stainless Steel

4.3.1. Stainless steel market estimates and forecasts, 2018 to 2030 (USD Million)

4.4. Glass

4.5. Others

Chapter 5. Filter Needles: End Use Estimates & Trend Analysis

5.1. Filter Needles Market, Key Takeaways

5.2. Filter Needles Market: Movement & Market Share Analysis, 2022 & 2030

5.3. Hospitals

5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)

5.4. Clinics

5.5. Ambulatory Surgery Centers

5.6. Others

Chapter 6. Filter Needles Market: Regional Estimates & Trend Analysis

6.1. Regional Outlook

6.2. Filter Needles Market by Region: Key Takeaways

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants

7.2. Company/Competition Categorization

For more information about this report visit https://www.researchandmarkets.com/r/fk2b76

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”